Resective epilepsy surgery: assessment of randomized controlled trials

Area of Science:

• Neurology
• Neurosurgery
• Clinical Trials

Background:

• Epilepsy is a common chronic neurological disorder.
• Medically intractable epilepsy persists despite adequate trials of antiepileptic drugs (AEDs).
• Resective epilepsy surgery is considered for select patients with difficult-to-treat epilepsy.

Purpose of the Study:

• To review randomized controlled trials (RCTs) on the efficacy of resective epilepsy surgery.
• To evaluate surgical approaches and extent of resection for optimal seizure control.
• To assess complication rates associated with resective epilepsy surgery.

Main Methods:

• Review of available randomized controlled trials (RCTs) examining resective epilepsy surgery.
• Analysis of seizure freedom rates in surgically treated versus medically treated patients.
• Evaluation of outcomes based on surgical approach and degree of hippocampal resection.

Main Results:

• Three RCTs demonstrated significant efficacy of resective surgery for mesial temporal lobe epilepsy, achieving 58-100% seizure freedom versus 0-13% in medical management.
• Seizure freedom rates were similar across different surgical approaches (transSylvian vs. subtemporal).
• Hippocampal resection is crucial for seizure control, with diminishing returns beyond 2.5 cm removal. Complication rates ranged from 2-11%, with visual field defects noted in up to 55%.

Conclusions:

• Resective surgery is a highly effective treatment for medically intractable mesial temporal lobe epilepsy.
• Optimal surgical strategy involves careful consideration of the surgical approach and extent of hippocampal resection.
• While effective, potential complications including visual field defects should be considered.